Combined Synopsis/Solicitation
NOI - DNA Sequencing of Bone Marrow Failure Syndro
Department of Health and Human Services · National Institutes of Health
AI summaryThe National Institutes of Health (NIH) plans to award a sole-source, firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) of Coralville, Iowa, for custom-designed ArcherDX VariantPlex DNA sequencing library preparation kits. Other firms may still send a capability statement, proposal or quotation by the response due date, November 2, 2026, 9:00 AM Eastern. More in the summary
AI summary Beta
The National Institutes of Health (NIH) plans to award a sole-source, firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) of Coralville, Iowa, for custom-designed ArcherDX VariantPlex DNA sequencing library preparation kits. Other firms may still send a capability statement, proposal or quotation by the response due date, November 2, 2026, 9:00 AM Eastern.
Who can bid
- Only the company the notice names can win this as planned: other firms may send a capability statement, and the agency decides whether that is enough to compete it.
Things to watch
From the version posted Oct 22, 2026.
- Serious: Sole-source award intended to IDT. NIH intends to award to one named company, so another firm would have to show it can supply the same chemistry to be considered.
- Serious: Proprietary chemistry named as required. The notice says IDT owns the ArcherDX VariantPlex chemistry, which is hard for a small business to match or resell.
- Worth checking: No submission method, quantities or place of performance given. The notice text does not say how to send a response, how many kits are needed, or where delivery happens.
Read from the notice text only.
Full summary
What they want
- Custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits
- The kits are for DNA sequencing of bone marrow failure syndromes, per the notice title
- The notice says the chemistry is needed to keep results consistent with sequencing done since 2019
- Contract type
- Firm-fixed-price (FFP: one set price, whatever the work ends up costing) purchase order, non-competitive
- Estimated value
- Not stated
- Offers due
- November 2, 2026, 9:00 AM Eastern
What to include when you submit
- Other sources may submit a capability statement, proposal or quotation
Current contractor
Integrated DNA Technologies, Inc. is named as the intended sole-source awardee; the notice says the NHLBI Hematology Branch has used its chemistry since 2019.
Not in the notice text
- How to submit a response (email address or portal) is not stated.
- The quantity of kits and their specifications are not stated.
- The delivery date and place of performance are not stated.
- The Government's estimated value is not stated; the notice says only that it is not expected to exceed the simplified acquisition threshold.
Eligibility and how to respond
- SAM.gov lists no set-aside, but the notice text limits who can bid:
- The notice text says this is set aside for small businesses, but SAM.gov lists no set-aside. Ask the contracting officer which one applies before you bid.
- How and where to submit is in the notice text and its attachments on SAM.gov.
Notice details
- Posted
- Oct 22, 2026
- Notice type
- Combined Synopsis/Solicitation
- Office
- National Institutes of Health Olao, Bethesda, MD
- Product/service code
- 6550 · In Vitro Diagnostic Substances, Reagents, Test Kits and Sets
- Business type
- Medical & healthcare (FedReady's grouping, from NAICS 325413)
- Attachments
Past awards and competition
Who has won work like this before, the likely incumbent, and what similar contracts paid, from USAspending.gov.
Before you respond
- How to respond to a solicitation (8 steps)
- How to read a government solicitation
- How to price a government contract
Terms on this notice: Solicitation
Full notice text from SAM.gov
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98027Q00027. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Integrated DNA Technologies, Inc. (IDT), 1710 Commercial Park, Coralville, IA 52241, for custom-designed ArcherDX VariantPlex Next-Generation Sequencing (NGS) target-enrichment library preparation kits. Integrated DNA Technologies, Inc. is the sole owner, manufacturer, and distributor of the proprietary ArcherDX VariantPlex Anchored Multiplex PCR (AMP) chemistry, which has been utilized by the NHLBI Hematology Branch since 2019 to perform error-correcting sequencing (ECS) and is required to maintain scientific continuity, prevent technical batch effects across longitudinal patient cohorts, and ensure compatibility with the laboratory's established Archer Analysis bioinformatics pipeline. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv) The associated NAICS code is 325413 (In-Vitro Diagnostic Substance Manufacturing) and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
Similar open opportunities
- VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQThe Department of Veterans Affairs (VA) wants Cepheid GeneXpert test kits for VA North Atlantic Health Network medical centers in Maryland, West Virginia and Washington, DC. This…
- Cepheid GeneXpert Testing SuppliesThe VA's Network Contract Office 5 plans to buy Cepheid GeneXpert testing supplies for six VA medical centers in West Virginia, Maryland and Washington DC. It expects one…
- Optilite analyzer reagents
- Hemochron Signature Elite Reagents and SuppliesThe Department of Veterans Affairs (Network Contracting Office 22) posted a sources sought notice, a request for information and not a solicitation, for Hemochron Signature Elite…
- BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systemsOnly service-disabled veteran-owned small businesses (SDVOSBs) can bid on this 100% set-aside.